Y-mAbs Therapeutics (YMAB) - Uzoq muddatli qarzning kapitalga nisbati

Y-mAbs Therapeutics (YMAB) korporativ emblemasi va logotipi

GURU.Markets platformasida quyida tasvirlangan Y-mAbs Therapeutics (YMAB) uchun joriy bozor kotirovkalari pediatrik sinovlarda bioetikaga va chiqindilarni yoqish bo'yicha ekologik standartlarga rioya qiladigan kompaniyaning narxlar dinamikasini aks ettiradi. Biznes pediatrik o'smalar uchun davolash vositalari portfelini kengaytirish orqali o'zining tijorat qamrovini faol ravishda oshirmoqda. 0.03 darajasiga yetgan rentabellik radio-immunoterapevtik antitelalarning tijoratlashtirilishi va tadqiqotlar muvaffaqiyati uchun hamkorlardan olinadigan bosqichma-bosqich to'lovlar bilan ta'minlanmoqda.

YmAbs - YMAB Uzoq muddatli qarzning kapitalga nisbati (davr: 04.07.2022 - 27.09.2025)

Y-mAbs Therapeutics kompaniyasining tahliliy kesimlari

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Y-mAbs Therapeutics Inc|YMAB - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi ko'rsatkichlari:
Bozor kapitallashuvi Y-mAbs Therapeutics, Inc.|YMAB - Kompaniyaning to‘liq qiymati
- kompaniyaning balans qiymati tafsilotlari:
Bitta aksiya hisobiga xususiy kapital Y-mAbs Therapeutics|YMAB - Balans kapitallashuvi|Kapitallashuvning sof aktivlarga nisbati ymabs.com|YMAB - Kompaniyaning umumiy aktivlari
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Qarzning kapitalga nisbati Y-mAbs Therapeutics|YMAB - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati ymabs.com|YMAB - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Y-mAbs Therapeutics, Inc.|YMAB - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Y-mAbs Therapeutics|Tezkor likvidlik koeffitsiyenti ymabs.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
YMAB - Kompaniyaning sof foydasi
Kompaniyaning umumiy tahlili:Y-mAbs Therapeutics Inc - YMAB
ymabs.com original mahsuloti

Ushbu ko'rsatkich majburiyatlarning bir yildan ortiq muddatli qismini umumiy kapital hajmi bilan solishtirish orqali emitentning uzoq muddatli to'lov qobiliyatini belgilaydi. Uzoq muddatli qarzdorlikning kapitalga nisbati grafigini tahlil qilish orqali investor kengayish salohiyatiga nisbatan defolt xavfini baholaydi, bu esa bolalar onkologiyasi sohasidagi qimmatli ishlanmalarni moliyalashtirish va grantlar orqali noyob mutaxassislarni saqlab qolishga yo'naltirilgan Y-mAbs Therapeutics (YMAB) kompaniyasining tadqiqotlarga asoslangan biznesi uchun juda muhimdir.

Muhim raqobatchilar

Uzoq muddatli qarzning o'z kapitaliga nisbati BeiGene Ltd. (ONC)|Uzoq muddatli qarzning kapitalga nisbati HALO|Uzoq muddatli qarzning kapitalga nisbati Revolution Medicines Corp (RVMD)|Uzoq muddatli qarzning o'z kapitaliga nisbati Ascentage Pharma Group AAPG|CGON: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|UroGen Pharma - Uzoq muddatli qarzning kapitalga nisbati|Bicara Therapeutics Inc (BCAX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|PSNL: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Erasca Oncology (ERAS)|Uzoq muddatli qarzning o'z kapitaliga nisbati Delcath Systems, Inc.|AURA: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati CADL (Candel Therapeutics)|ARAY (Accuray Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati SLS (SELLAS Life Sciences Group)|ACTU - Uzoq muddatli qarzning o'z kapitaliga nisbati|CTOR: Uzoq muddatli qarzning o'z kapitaliga nisbati|HURA - Uzoq muddatli qarzning kapitalga nisbati|Protara Therapeutics, Inc. (TARA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Fate Therapeutics Inc - Uzoq muddatli qarzning kapitalga koeffitsiyenti|WHWK (Aadi Bioscience, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati TScan TCRX|Uzoq muddatli qarzning o'z kapitaliga nisbati CSBR (Champions Oncology)|XBIT - Uzoq muddatli majburiyatlarning kapitalga nisbati|CEL-SCI - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati OS Therapies Inc.|RADX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Artiva Biotherapeutics, Inc. (ARTV) - Uzoq muddatli qarzning o'z kapitaliga nisbati|ANL: Uzoq muddatli qarzning kapitalga nisbati|verupharma.com (VERU) - Uzoq muddatli qarzning kapitalga nisbati|TPST (Tempest Therapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati XLO|Uzoq muddatli qarzning o'z kapitaliga nisbati Renovaro Inc. (RENB)|Uzoq muddatli qarzdorlikning kapitalga nisbati muraloncology.com|Kairos Pharma - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti OKUR|GDTC: Uzoq muddatli qarzning o'z kapitaliga nisbati|Curis, Inc. - Uzoq muddatli kreditlarning kapitalga nisbati|APLM: Uzoq muddatli qarzning kapitalga nisbati|Tharimmune Corporation - Uzoq muddatli qarzning kapitalga koeffitsiyenti|ADVB (Advanced Biomed Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati genprex.com GNPX|Uzoq muddatli qarzning o'z kapitaliga nisbati Calidi Biotherapeutics (CLDI)|SBFM (Sunshine Biopharma Inc.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati XBIO (Xenetic Biosciences, Inc.)|Uzoq muddatli qarzning kapitalga nisbati Salarius Pharma SLRX|PPBT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati AONC|BGNE: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Checkpoint Therapeutics Inc. (CKPT)|Uzoq muddatli qarzning o'z kapitaliga nisbati ELEV|Uzoq muddatli qarzning kapitalga nisbati iCAD Corp|Uzoq muddatli qarzning o'z kapitaliga nisbati IKNA (Ikena Oncology, Inc.)|Uzoq muddatli kreditlarning kapitalga nisbati NTBL|Uzoq muddatli qarzning kapitalga nisbati VIRX (Viracta Therapeutics, Inc.)|Uzoq muddatli qarzdorlikning kapitalga nisbati MorphoSys Inc (MOR)|NAYA Bio - Uzoq muddatli qarzning kapitalga nisbati|Ascentage (AAPGV) - Uzoq muddatli qarzning o'z kapitaliga nisbati